Insilico's AI Bet on Human Longevity
An AI-designed drug for scarred lungs is in Phase III, the company has a pipeline of around 40 programs, and its CEO talks about humans living to 150. What the science shows, and why a younger score on an aging clock is not the same as aging backwards.
Loading full article...